pAd-musRunx1-sh3 |
重组载体 |
基因信息:http://www.ncbi.nlm.nih.gov/nuccore/NM_001111021.2
|
pAd-musSlit2-sh5 |
重组载体 |
基因信息:http://www.ncbi.nlm.nih.gov/nuccore/NM_001291227.1
|
pAd-musSlit2-sh1 |
重组载体 |
基因信息:http://www.ncbi.nlm.nih.gov/nuccore/NM_001291227.1
|
pYr-ads-4-ratBMP2 |
pYr-ads-4 |
抗性:Kan+
基因信息:http://www.ncbi.nlm.nih.gov/nuccore/NM_017178.1
|
pYr-ads-4-ratGpnmb |
pYr-ads-4 |
抗性:Kan+
基因信息:http://www.ncbi.nlm.nih.gov/nuccore/NM_133298.1
|
pCMV-HA-SerpinB5-C |
pCMV-HA |
抗性:Amp+
基因信息:Homo sapiens serpin peptidase inhibitor, clade B (ovalbumin), member 5 (SERPINB5), mRNA,NM_002639.4,CDS 区 143..1270
|
pIRES2-zsgreen1-CYP2E1 |
pIRES2-zsgreen1 |
抗性:Kan+
基因信息:Homo sapiens cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1), mRNA.NM_000773
|
SD皮层神经胶质细胞的分离和冻存 |
|
|
pYr-ads-4-CD274 |
pYr-ads-4 |
抗性:Kan+
基因信息:Homo sapiens CD274 molecule (Cd274,B7h1,Pdcd1l1,Pdcd1lg1,Pdl1), mRNA. NM_014143 BC113734
|
pAd-4-NAA11 |
重组载体 |
基因信息:Homo sapiens N(alpha)-acetyltransferase 11, NatA catalytic subunit(NAA11,ARD1B), mRNA NM_032693
|
pAd-4-FAM82A2 |
重组载体 |
基因信息:Homo sapiens family with sequence similarity 82, member A2 (FAM82A2), mRNA.NM_018145
|
pAd-4-ELP6 |
重组载体 |
基因信息:Homo sapiens elongator acetyltransferase complex subunit 6 (ELP6), mRNA.NM_001031703
|
pAd-4-NAA10 |
重组载体 |
基因信息:Homo sapiens N(alpha)-acetyltransferase 10, NatA catalytic subunit(NAA10,ARD1A), transcript variant 1, mRNA NM_003491
|
pAd-4-FKBP5 |
重组载体 |
基因信息:Homo sapiens FK506 binding protein 5 (FKBP5), transcript variant 1, mRNA. NM_004117
|
pAd-4-KCNJ2 |
重组载体 |
基因信息:http://www.ncbi.nlm.nih.gov/nuccore/NM_000891.2
|
pAd-4-ratAPEX1 |
重组载体 |
基因信息:Rattus norvegicus APEX nuclease (multifunctional DNA repair enzyme)1 (Apex1), mRNA NM_024148
|
pYr-MirTarget-ratArrb2-3u-M |
pYr-MirTarget |
抗性:Amp+
|
TS-ratTPCN2-NM |
pUC-57 |
抗性:Amp+
基因信息:http://www.ncbi.nlm.nih.gov/nuccore/XM_006230784.1
|
pCMV-HA-SerpinB5-N |
pCMV-HA |
抗性:Amp+
基因信息:http://www.ncbi.nlm.nih.gov/nuccore/NM_002639.4
|
pCMV-HA-SerpinB5 |
pCMV-HA |
抗性:Amp+
基因信息:http://www.ncbi.nlm.nih.gov/nuccore/NM_002639.4
|